Top Banner
ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology The University of Texas MD Anderson Cancer center
12

ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology The University of Texas MD Anderson Cancer center.

Jan 21, 2016

Download

Documents

Jonas Payne
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology The University of Texas MD Anderson Cancer center.

ZHIHONG HU, MD, PhD

Fellow, Department of HematopahtologyThe University of Texas

MD Anderson Cancer center

Page 2: ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology The University of Texas MD Anderson Cancer center.

CLINICAL HISTORY

• A 25-year-old man diagnosed with rheumatoid arthritis for the past 3 years

• On follow-up of a repeat CBC, significant leukocytosis with eosinophilia about 6 months

• Had an extensive workup done: negative for ova and parasites, strongyloids

• A bone marrow biopsy was completely negative, negative for BCR-ABL, JAK2 , PDGFR alpha and beta

• Echocardiogram was negative

Page 3: ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology The University of Texas MD Anderson Cancer center.

• For his RA, treated with methotrexate• Switched to leflunomide for the past month due

to intolerance to methotrexate• Not much complaints, except for two nodules on

the right leg, and other symptoms secondary to RA (joint stiffness and swelling (small joints of his hands, elbows and wrists) in the morning that lasts more than 1 hour, which is consistent with his RA

• No good reason for his underlying eosinophilia other than his rheumatoid arthritis

CLINICAL HISTORY (cont’d)

Page 4: ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology The University of Texas MD Anderson Cancer center.

ANCILLARY STUDIES•CBC: WBC 38.2K/L H (4.0-11.0)RBC 4.50M/L (4.50-6.00)Hgb 13.9gm/dL L (14.0-18.0)Neutrophil: 22.0% L (42.0-66.0); 8.40K/L H (1.70-7.30), Lymphocyte:15.0% L(24.0-44.0); 5.73K/L H (1.00-4.80)Monocyte: 2.0% (2.0-7.0); 0.76K/L H (0.08-0.70), Eosinophil: 61.0% H (1.0-4.0); 23.30K/L H (0.04-0.40)

•Sodium 139, potassium 4.4, chloride 104, bicarb 28, BUN 7, creatinine 0.84, glucose 47

Page 5: ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology The University of Texas MD Anderson Cancer center.

PERIPHERAL BLOOD SMEAR

Page 6: ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology The University of Texas MD Anderson Cancer center.

BONE MARROW BIOPSY

Page 7: ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology The University of Texas MD Anderson Cancer center.
Page 8: ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology The University of Texas MD Anderson Cancer center.
Page 9: ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology The University of Texas MD Anderson Cancer center.
Page 10: ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology The University of Texas MD Anderson Cancer center.
Page 11: ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology The University of Texas MD Anderson Cancer center.

PROPOSED DIAGNOSIS

• Cellular (80%) bone marrow with trilineage hematopoiesis and marked eosinophilia, compatible with LYMPHOCYTE VARIANT OF HYPEREOSINOPHILIC SYNDROME

• Sub-diagnostic systemic mastocytosis

Page 12: ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology The University of Texas MD Anderson Cancer center.

TAKE HOME MASSAGE

• Aberrant T cell population of CD3-CD4+ immunophenotype is seen in the lymphoid variant of hypereosinophilic syndrome (L-HES)

• Monoclonal TCR gamma gene arrangement can be detected in L-HES

• Sub-diagnostic systemic mastocytosis: those meeting 1-2 minor criteria for SM only